Last updated: November 21, 2025
Sponsor: University of Minnesota
Overall Status: Completed
Phase
N/A
Condition
Alport's Syndrome
Kidney Failure (Pediatric)
Nephropathy
Treatment
N/AClinical Study ID
NCT00481130
0704M05941
Ages < 99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: History of a diagnosis of Alport syndrome, Family or individuals need to be able to comprehend the consent and HIPAA forms written in the English language.
Exclusion
Exclusion Criteria: Uncertain diagnosis of Alport syndrome.
Study Design
Total Participants: 655
Study Start date:
September 01, 2007
Estimated Completion Date:
November 17, 2025
Study Description
Connect with a study center
University of Minnesota
Minneapolis, Minnesota 55455
United StatesSite Not Available
University of Minnesota
Minneapolis 5037649, Minnesota 5037779 55455
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.